22nd Century Group (XXII) Earnings Date & Reports

Key Takeaways

• 22nd Century Group is scheduled to report its third quarter 2026 results on November 16, 2026, after releasing preliminary figures in late October.
• Preliminary results point to net revenue of about $4.8 million, up 66% from $2.9 million in the second quarter of 2026.
• Gross profit turned positive at roughly $0.4 million, compared with a $0.3 million gross loss in the prior quarter.
• The company still expects a net loss of approximately $2.6 million, narrower than the $3.3 million loss reported in the second quarter.
• Cash and equivalents stood at $3.9 million at quarter end, with no warrants remaining outstanding.
• For more context, explore 22nd Century Group's Major News, Today's Price Move, Price Targets, and Forecast on dedicated pages.
• Discover Trending AI Robots to see AI-driven trading strategies currently drawing attention in the market.

Earnings Context and Why It Matters

22nd Century Group is a small-cap tobacco company and the only maker of low-nicotine cigarettes in the world. Its flagship VLN® products contain roughly 95% less nicotine than traditional cigarettes, positioning the company at the center of the tobacco harm-reduction movement. After exiting unprofitable, high-volume revenue streams in 2025, the company ended that year debt-free and has been working to rebuild a higher-margin, branded product business. The third quarter 2026 report is important because it offers the first clear read on whether that turnaround is gaining traction, with preliminary data suggesting revenue growth and a return to positive gross profit.

Earnings Expectations

Because 22nd Century Group released preliminary results on October 22, 2026, investors already have a framework for what the formal report should show. Management expects net revenue of approximately $4.8 million for the third quarter, a 66% sequential increase from $2.9 million in the second quarter. Gross profit is expected to reach about $0.4 million, swinging positive from a $0.3 million gross loss. The company anticipates operating expenses of $3.0 million and a net loss of roughly $2.6 million, an improvement from the prior quarter's $3.3 million loss.

The November 16 announcement will deliver the fully reviewed results prepared under generally accepted accounting principles (GAAP, the standard rules for U.S. financial reporting), including final earnings per share, along with any updated guidance. Investors will also watch adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization, a measure of core operating performance), which is preliminarily expected to show a $2.2 million loss, narrower than the $3.5 million loss in the second quarter.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, making it a practical resource for investors tracking names like XXII.

Market Reaction and Investor Sentiment

Sentiment heading into the report is cautious but attentive. XXII has a relatively small share count—about 3.4 million common shares outstanding as of late October—which can amplify price swings around news. The stock has experienced significant volatility in 2026, including corporate actions such as reverse stock splits that have reshaped its share structure. The preliminary results, highlighted by a 66% revenue jump and a return to positive gross profit, were received as an encouraging sign that the low-nicotine strategy is beginning to convert into improving financials. Still, the company remains unprofitable and holds a modest cash balance, so investors are weighing the progress against ongoing liquidity and execution risk as the formal results and any forward commentary approach.

Forward Outlook and Key Factors to Monitor

The most important factor to watch after the report is distribution. Management has been expanding the reach of its VLN® and Partner VLN® cigarette brands, and same-store sales growth is a key signal of consumer acceptance. Any commentary on retail outlet counts, repeat purchase behavior, or new brand partnerships will matter more than the headline revenue figure alone.

Margin trajectory is another focal point. The shift from a gross loss to positive gross profit is meaningful, but investors will want to see whether that improvement can be sustained as the company scales production and moves toward profitability. Operating expense discipline and the rate at which losses narrow will also be closely watched.

Finally, cash and liquidity remain critical. With roughly $3.9 million in cash at quarter end and no long-term debt, the company has breathing room, but its runway depends on continued revenue growth and disciplined spending. Regulatory developments tied to the U.S. Food and Drug Administration's stance on reduced-nicotine tobacco could also shape the outlook, given that 22nd Century Group is currently the only commercial provider of such products.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations